ReP USP - Resultado da busca

Artigo de periodico
Use of metabolomics approach in the discovery of active compounds from Macroalgae Laurencia species against schistosomiasis (2025)
Soares, Amanda Beatriz Silva ; Miyasato, Patricia Aoki ; Freitas, Rafaela Paula de ; Maleski, Adolfo Luis Almeida ; Pimenta, Daniel Carvalho ; Colepicolo, Pio ; Stein, Erika Mattos ; Macedo, Arthur Ladeira ; Carollo, Carlos Alexandre ; Nakano, Eliana
Fonte: Pharmaceutics. Unidades: IQ, Interunidades em Biotecnologia
Assuntos: MACROALGAS, ESQUISTOSSOMOSE, SCHISTOSOMA MANSONI, METABOLÔMICA, PRODUTOS NATURAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOARES, Amanda Beatriz Silva et al. Use of metabolomics approach in the discovery of active compounds from Macroalgae Laurencia species against schistosomiasis. Pharmaceutics, v. 17, n. 10, p. 1-18 art. 1294, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics17101294. Acesso em: 05 dez. 2025.
APA
Soares, A. B. S., Miyasato, P. A., Freitas, R. P. de, Maleski, A. L. A., Pimenta, D. C., Colepicolo, P., et al. (2025). Use of metabolomics approach in the discovery of active compounds from Macroalgae Laurencia species against schistosomiasis. Pharmaceutics, 17( 10), 1-18 art. 1294. doi:10.3390/pharmaceutics17101294
NLM
Soares ABS, Miyasato PA, Freitas RP de, Maleski ALA, Pimenta DC, Colepicolo P, Stein EM, Macedo AL, Carollo CA, Nakano E. Use of metabolomics approach in the discovery of active compounds from Macroalgae Laurencia species against schistosomiasis [Internet]. Pharmaceutics. 2025 ; 17( 10): 1-18 art. 1294.[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics17101294
Vancouver
Soares ABS, Miyasato PA, Freitas RP de, Maleski ALA, Pimenta DC, Colepicolo P, Stein EM, Macedo AL, Carollo CA, Nakano E. Use of metabolomics approach in the discovery of active compounds from Macroalgae Laurencia species against schistosomiasis [Internet]. Pharmaceutics. 2025 ; 17( 10): 1-18 art. 1294.[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics17101294
Artigo de periodico
Easy obtainment and biological applicability of pinocarvyl acetate by encapsulating of the Microlicia graveolens essential oil in oil-in-water nanoemulsions (2025)
Seibert, Janaína Brandão ; Amparo, Tatiane Roquete ; Sousa, Lucas Resende Dutra; Rodrigues, Ivanildes Vasconcelos ; Petit, Alicia; Pervier, Pauline; Azevedo, Mariana Costa; Sales Junior, Policarpo Ademar ; Murta, Silvane M. F. ; Carneiro, Cláudia Martins ; Teixeira, Luiz Fernando de Medeiros; Souza, Gustavo Henrique Bianco de; Vieira, Paula Melo de Abreu ; Santos, Orlando David Henrique dos
Fonte: Pharmaceutics. Unidade: ESALQ
Assuntos: AGENTES ANTIMICROBIANOS, CETONA, MICROENCAPSULAÇÃO, NANOTECNOLOGIA, ÓLEOS ESSENCIAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SEIBERT, Janaína Brandão et al. Easy obtainment and biological applicability of pinocarvyl acetate by encapsulating of the Microlicia graveolens essential oil in oil-in-water nanoemulsions. Pharmaceutics, v. 17, p. 1-16, 2025Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics17091130. Acesso em: 05 dez. 2025.
APA
Seibert, J. B., Amparo, T. R., Sousa, L. R. D., Rodrigues, I. V., Petit, A., Pervier, P., et al. (2025). Easy obtainment and biological applicability of pinocarvyl acetate by encapsulating of the Microlicia graveolens essential oil in oil-in-water nanoemulsions. Pharmaceutics, 17, 1-16. doi:10.3390/pharmaceutics17091130
NLM
Seibert JB, Amparo TR, Sousa LRD, Rodrigues IV, Petit A, Pervier P, Azevedo MC, Sales Junior PA, Murta SMF, Carneiro CM, Teixeira LF de M, Souza GHB de, Vieira PM de A, Santos ODH dos. Easy obtainment and biological applicability of pinocarvyl acetate by encapsulating of the Microlicia graveolens essential oil in oil-in-water nanoemulsions [Internet]. Pharmaceutics. 2025 ; 17 1-16.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics17091130
Vancouver
Seibert JB, Amparo TR, Sousa LRD, Rodrigues IV, Petit A, Pervier P, Azevedo MC, Sales Junior PA, Murta SMF, Carneiro CM, Teixeira LF de M, Souza GHB de, Vieira PM de A, Santos ODH dos. Easy obtainment and biological applicability of pinocarvyl acetate by encapsulating of the Microlicia graveolens essential oil in oil-in-water nanoemulsions [Internet]. Pharmaceutics. 2025 ; 17 1-16.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics17091130
Artigo de periodico
Hydrogel containing biogenic silver nanoparticles and origanum vulgare essential oil for burn wounds: antimicrobial efficacy using ex vivo and in vivo methods against multidrug-resistant microorganisms (2025)
Kimura, Angela Hitomi ; Dahmer, Débora ; Isawa, Luana Ayumi ; Silva, Ana Beatriz Olivetti da ; Souza, Lucas Marcelino dos Santos ; Takata, Pedro Henrique ; Scandorieiro, Sara ; Deonas, Anastácia Nikolaos ; Germiniani-Cardozo, Jennifer ; Vespero, Eliana Carolina ; Perugini, Marcia Regina Eches ; Lonni, Audrey Alesandra Stinghen Garcia ; Nakazato, Gerson ; Kobayashi, Renata Katsuko Takayama ; Lincopan, Nilton
Fonte: Pharmaceutics. Unidade: ICB
Assuntos: MICROBIOLOGIA, NANOPARTÍCULAS, GEL (FORMAS FARMACÊUTICAS), INFECÇÕES BACTERIANAS GRAM-NEGATIVAS, INFECÇÕES BACTERIANAS GRAM-POSITIVAS, QUEIMADURAS, NANOTECNOLOGIA, ÓLEOS ESSENCIAIS, PELE DE ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KIMURA, Angela Hitomi et al. Hydrogel containing biogenic silver nanoparticles and origanum vulgare essential oil for burn wounds: antimicrobial efficacy using ex vivo and in vivo methods against multidrug-resistant microorganisms. Pharmaceutics, v. 17, n. 4, p. 23 , 2025Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics17040503. Acesso em: 05 dez. 2025.
APA
Kimura, A. H., Dahmer, D., Isawa, L. A., Silva, A. B. O. da, Souza, L. M. dos S., Takata, P. H., et al. (2025). Hydrogel containing biogenic silver nanoparticles and origanum vulgare essential oil for burn wounds: antimicrobial efficacy using ex vivo and in vivo methods against multidrug-resistant microorganisms. Pharmaceutics, 17( 4), 23 . doi:10.3390/pharmaceutics17040503
NLM
Kimura AH, Dahmer D, Isawa LA, Silva ABO da, Souza LM dos S, Takata PH, Scandorieiro S, Deonas AN, Germiniani-Cardozo J, Vespero EC, Perugini MRE, Lonni AASG, Nakazato G, Kobayashi RKT, Lincopan N. Hydrogel containing biogenic silver nanoparticles and origanum vulgare essential oil for burn wounds: antimicrobial efficacy using ex vivo and in vivo methods against multidrug-resistant microorganisms [Internet]. Pharmaceutics. 2025 ; 17( 4): 23 .[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics17040503
Vancouver
Kimura AH, Dahmer D, Isawa LA, Silva ABO da, Souza LM dos S, Takata PH, Scandorieiro S, Deonas AN, Germiniani-Cardozo J, Vespero EC, Perugini MRE, Lonni AASG, Nakazato G, Kobayashi RKT, Lincopan N. Hydrogel containing biogenic silver nanoparticles and origanum vulgare essential oil for burn wounds: antimicrobial efficacy using ex vivo and in vivo methods against multidrug-resistant microorganisms [Internet]. Pharmaceutics. 2025 ; 17( 4): 23 .[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics17040503
Artigo de periodico
[99mTc] Technetium and rhenium dithiocarbazate complexes: Chemical synthesis and biological assessment (2025)
Fernandes, André Gustavo de Araujo; Lafratta, Alyne Eloise; Luz, Carolina Portela; Levy, Débora ; Faria, Daniele de Paula ; Buchpiguel, Carlos Alberto ; Abram, Ulrich ; Deflon, Victor Marcelo ; Marques, Fabio Luiz Navarro
Fonte: Pharmaceutics. Unidades: FM, IQSC
Assuntos: RÊNIO, TECNÉCIO, TUMOR CARCINOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FERNANDES, André Gustavo de Araujo et al. [99mTc] Technetium and rhenium dithiocarbazate complexes: Chemical synthesis and biological assessment. Pharmaceutics, v. 17, p. 100, 2025Tradução . . Disponível em: https://doi.org/10.3390/ pharmaceutics17010100. Acesso em: 05 dez. 2025.
APA
Fernandes, A. G. de A., Lafratta, A. E., Luz, C. P., Levy, D., Faria, D. de P., Buchpiguel, C. A., et al. (2025). [99mTc] Technetium and rhenium dithiocarbazate complexes: Chemical synthesis and biological assessment. Pharmaceutics, 17, 100. doi:10.3390/ pharmaceutics17010100
NLM
Fernandes AG de A, Lafratta AE, Luz CP, Levy D, Faria D de P, Buchpiguel CA, Abram U, Deflon VM, Marques FLN. [99mTc] Technetium and rhenium dithiocarbazate complexes: Chemical synthesis and biological assessment [Internet]. Pharmaceutics. 2025 ;17 100.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/ pharmaceutics17010100
Vancouver
Fernandes AG de A, Lafratta AE, Luz CP, Levy D, Faria D de P, Buchpiguel CA, Abram U, Deflon VM, Marques FLN. [99mTc] Technetium and rhenium dithiocarbazate complexes: Chemical synthesis and biological assessment [Internet]. Pharmaceutics. 2025 ;17 100.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/ pharmaceutics17010100
Artigo de periodico
Amino compound-synthesized gold nanoparticles for SARS-CoV-2 antigen delivery (2025)
Rego, Layane Souza ; Favaro, Marianna Teixeira de Pinho ; Jesus, Mônica Josiane Rodrigues de ; Santos, Robert Andreata ; Janini, Luiz Mário Ramos ; Seckler, Marcelo Martins ; Ferreira, Luís Carlos de Souza ; Azzoni, Adriano Rodrigues
Fonte: Pharmaceutics. Unidades: EP, ICB
Assunto: MICROBIOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
REGO, Layane Souza et al. Amino compound-synthesized gold nanoparticles for SARS-CoV-2 antigen delivery. Pharmaceutics, v. 17, 2025Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics17091211. Acesso em: 05 dez. 2025.
APA
Rego, L. S., Favaro, M. T. de P., Jesus, M. J. R. de, Santos, R. A., Janini, L. M. R., Seckler, M. M., et al. (2025). Amino compound-synthesized gold nanoparticles for SARS-CoV-2 antigen delivery. Pharmaceutics, 17. doi:10.3390/pharmaceutics17091211
NLM
Rego LS, Favaro MT de P, Jesus MJR de, Santos RA, Janini LMR, Seckler MM, Ferreira LC de S, Azzoni AR. Amino compound-synthesized gold nanoparticles for SARS-CoV-2 antigen delivery [Internet]. Pharmaceutics. 2025 ; 17[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics17091211
Vancouver
Rego LS, Favaro MT de P, Jesus MJR de, Santos RA, Janini LMR, Seckler MM, Ferreira LC de S, Azzoni AR. Amino compound-synthesized gold nanoparticles for SARS-CoV-2 antigen delivery [Internet]. Pharmaceutics. 2025 ; 17[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics17091211
Artigo de periodico
Curcumin microcapsule formulations for prolong persistence in the photodynamic inactivation of Aedes aegypti larvae (2025)
Garbuio, Matheus ; Souza, Larissa Marila de ; Dias, Lucas Danilo ; Machado, Jean Carlos Ferreira; Inada, Natalia Mayumi ; Barud, Hernane da Silva ; Sanches, Edgar Aparecido ; Guimarães, Francisco Eduardo Gontijo ; Silva, Ana Paula da; Lima, Alessandra Ramos ; Bagnato, Vanderlei Salvador
Fonte: Pharmaceutics. Unidade: IFSC
Assuntos: TERAPIA FOTODINÂMICA, CONTROLE DE VETORES, DENGUE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GARBUIO, Matheus et al. Curcumin microcapsule formulations for prolong persistence in the photodynamic inactivation of Aedes aegypti larvae. Pharmaceutics, v. 17, n. 4, p. 496-1-496-33 + supplementary materials, 2025Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics17040496. Acesso em: 05 dez. 2025.
APA
Garbuio, M., Souza, L. M. de, Dias, L. D., Machado, J. C. F., Inada, N. M., Barud, H. da S., et al. (2025). Curcumin microcapsule formulations for prolong persistence in the photodynamic inactivation of Aedes aegypti larvae. Pharmaceutics, 17( 4), 496-1-496-33 + supplementary materials. doi:10.3390/pharmaceutics17040496
NLM
Garbuio M, Souza LM de, Dias LD, Machado JCF, Inada NM, Barud H da S, Sanches EA, Guimarães FEG, Silva AP da, Lima AR, Bagnato VS. Curcumin microcapsule formulations for prolong persistence in the photodynamic inactivation of Aedes aegypti larvae [Internet]. Pharmaceutics. 2025 ; 17( 4): 496-1-496-33 + supplementary materials.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics17040496
Vancouver
Garbuio M, Souza LM de, Dias LD, Machado JCF, Inada NM, Barud H da S, Sanches EA, Guimarães FEG, Silva AP da, Lima AR, Bagnato VS. Curcumin microcapsule formulations for prolong persistence in the photodynamic inactivation of Aedes aegypti larvae [Internet]. Pharmaceutics. 2025 ; 17( 4): 496-1-496-33 + supplementary materials.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics17040496
Artigo de periodico
Nanoencapsulation of biotics: feasibility to enhance stability and delivery for improved gut health (2025)
Silva, Pedro Brivaldo Viana da; Rosales, Thiécla Katiane Osvaldt ; Fabi, João Paulo
Fonte: Pharmaceutics. Unidade: FCF
Assuntos: PROBIÓTICOS, PREBIÓTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA, Pedro Brivaldo Viana da e ROSALES, Thiécla Katiane Osvaldt e FABI, João Paulo. Nanoencapsulation of biotics: feasibility to enhance stability and delivery for improved gut health. Pharmaceutics, v. 17, n. 9, p. 1-23 art. 1180, 2025Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics17091180. Acesso em: 05 dez. 2025.
APA
Silva, P. B. V. da, Rosales, T. K. O., & Fabi, J. P. (2025). Nanoencapsulation of biotics: feasibility to enhance stability and delivery for improved gut health. Pharmaceutics, 17( 9), 1-23 art. 1180. doi:10.3390/pharmaceutics17091180
NLM
Silva PBV da, Rosales TKO, Fabi JP. Nanoencapsulation of biotics: feasibility to enhance stability and delivery for improved gut health [Internet]. Pharmaceutics. 2025 ; 17( 9): 1-23 art. 1180.[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics17091180
Vancouver
Silva PBV da, Rosales TKO, Fabi JP. Nanoencapsulation of biotics: feasibility to enhance stability and delivery for improved gut health [Internet]. Pharmaceutics. 2025 ; 17( 9): 1-23 art. 1180.[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics17091180
Artigo de periodico
Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models (2025)
Lima, Mauro Almeida ; Teixeira, Tamara ; Fortaleza, Dario Batista ; Pereira, George Bueno Santana ; Akinyemi, Amos Olalekan ; Moraes, Carlos André Ferreira ; Forim, Moacir Rossi ; Batista, Alzir Azevedo ; Dutra, Jocely de Lucena ; de Araujo Neto, João Honorato ; Ellena, Javier ; Rocha, Fillipe Vieira
Fonte: Pharmaceutics. Unidades: IQ, IFSC
Assuntos: NEOPLASIAS OVARIANAS, ANTINEOPLÁSICOS, CITOTOXINAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Mauro Almeida et al. Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models. Pharmaceutics, v. 17, n. 7, p. 829-1-829-23 + supplementary materials, 2025Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics17070829. Acesso em: 05 dez. 2025.
APA
Lima, M. A., Teixeira, T., Fortaleza, D. B., Pereira, G. B. S., Akinyemi, A. O., Moraes, C. A. F., et al. (2025). Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models. Pharmaceutics, 17( 7), 829-1-829-23 + supplementary materials. doi:10.3390/pharmaceutics17070829
NLM
Lima MA, Teixeira T, Fortaleza DB, Pereira GBS, Akinyemi AO, Moraes CAF, Forim MR, Batista AA, Dutra J de L, de Araujo Neto JH, Ellena J, Rocha FV. Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models [Internet]. Pharmaceutics. 2025 ; 17( 7): 829-1-829-23 + supplementary materials.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics17070829
Vancouver
Lima MA, Teixeira T, Fortaleza DB, Pereira GBS, Akinyemi AO, Moraes CAF, Forim MR, Batista AA, Dutra J de L, de Araujo Neto JH, Ellena J, Rocha FV. Enhanced anticancer potential of Pd(II)-Thiosemicarbazone complexes: selectivity, mechanisms, and 3D models [Internet]. Pharmaceutics. 2025 ; 17( 7): 829-1-829-23 + supplementary materials.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics17070829
Artigo de periodico
Antiviral Action against SARS-CoV-2 of a synthetic peptide based on a novel defensin present in the transcriptome of the fire salamander (Salamandra salamandra) (2024)
Barros, Ana Luisa Alves Nogueira ; Silva, Vladimir Costa ; Ribeiro Junior, Atvaldo F; Cardoso, Miguel G; Costa, Samuel R; Moraes, Carolina Borsoi ; Barbosa, Cecília G; Coleone, Alex P; Simões, Rafael Plana ; Cabral, Wanessa F; Falcão, Raul M; Vasconcelos, Andreanne Gomes ; Rocha, Jefferson Almeida ; Arcanjo, Daniel Dias Rufino ; Batagin Neto, Augusto ; Borges, Tatiana Karla dos Santos ; Gonçalves, João; Freitas-Junior, Lucio H. G; Eaton, Peter; Marani, Mariela ; Kato, Massuo Jorge ; Plácido, Alexandra ; Leite, José Roberto S. A
Fonte: Pharmaceutics. Unidade: IQ
Assuntos: CAUDATA, ANTIVIRAIS, PEPTÍDEOS, BIOINFORMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARROS, Ana Luisa Alves Nogueira et al. Antiviral Action against SARS-CoV-2 of a synthetic peptide based on a novel defensin present in the transcriptome of the fire salamander (Salamandra salamandra). Pharmaceutics, v. 16, p. 1-19 art. 190, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16020190. Acesso em: 05 dez. 2025.
APA
Barros, A. L. A. N., Silva, V. C., Ribeiro Junior, A. F., Cardoso, M. G., Costa, S. R., Moraes, C. B., et al. (2024). Antiviral Action against SARS-CoV-2 of a synthetic peptide based on a novel defensin present in the transcriptome of the fire salamander (Salamandra salamandra). Pharmaceutics, 16, 1-19 art. 190. doi:10.3390/pharmaceutics16020190
NLM
Barros ALAN, Silva VC, Ribeiro Junior AF, Cardoso MG, Costa SR, Moraes CB, Barbosa CG, Coleone AP, Simões RP, Cabral WF, Falcão RM, Vasconcelos AG, Rocha JA, Arcanjo DDR, Batagin Neto A, Borges TK dos S, Gonçalves J, Freitas-Junior LHG, Eaton P, Marani M, Kato MJ, Plácido A, Leite JRSA. Antiviral Action against SARS-CoV-2 of a synthetic peptide based on a novel defensin present in the transcriptome of the fire salamander (Salamandra salamandra) [Internet]. Pharmaceutics. 2024 ; 16 1-19 art. 190.[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16020190
Vancouver
Barros ALAN, Silva VC, Ribeiro Junior AF, Cardoso MG, Costa SR, Moraes CB, Barbosa CG, Coleone AP, Simões RP, Cabral WF, Falcão RM, Vasconcelos AG, Rocha JA, Arcanjo DDR, Batagin Neto A, Borges TK dos S, Gonçalves J, Freitas-Junior LHG, Eaton P, Marani M, Kato MJ, Plácido A, Leite JRSA. Antiviral Action against SARS-CoV-2 of a synthetic peptide based on a novel defensin present in the transcriptome of the fire salamander (Salamandra salamandra) [Internet]. Pharmaceutics. 2024 ; 16 1-19 art. 190.[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16020190
Artigo de periodico
Emerging cationic nanovaccines (2024)
Carmona-Ribeiro, Ana Maria ; Betancourt, Yunys Pérez
Fonte: Pharmaceutics. Unidade: IQ
Assuntos: NANOPARTÍCULAS, IMUNOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CARMONA-RIBEIRO, Ana Maria e BETANCOURT, Yunys Pérez. Emerging cationic nanovaccines. Pharmaceutics, v. 16, n. 11, p. 31 art. 1362, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16111362. Acesso em: 05 dez. 2025.
APA
Carmona-Ribeiro, A. M., & Betancourt, Y. P. (2024). Emerging cationic nanovaccines. Pharmaceutics, 16( 11), 31 art. 1362. doi:10.3390/pharmaceutics16111362
NLM
Carmona-Ribeiro AM, Betancourt YP. Emerging cationic nanovaccines [Internet]. Pharmaceutics. 2024 ; 16( 11): 31 art. 1362.[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16111362
Vancouver
Carmona-Ribeiro AM, Betancourt YP. Emerging cationic nanovaccines [Internet]. Pharmaceutics. 2024 ; 16( 11): 31 art. 1362.[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16111362
Artigo de periodico
A new heteroleptic Zn(II) complex with Schiff bases sensitizes triple-negative breast cancer cells to Doxorubicin and Paclitaxel (2024)
Machado, Raiane Aparecida dos Santos; Siqueira, Raoni Pais; Silva, Fernanda Cardoso da; Matos, André Carlos Pereira de; Borges, Dayanne Silva; Rocha, Gislaine Gonçalves; Souza, Thais Cristina Prado de; Souza, Rafael Aparecido Carvalho; Oliveira, Clayton Rodrigues de; Ferreira, Antônio Gilberto ; Maia, Pedro Ivo da Silva ; Deflon, Victor Marcelo ; Oliveira, Carolina Gonçalves; Araújo, Thaise Gonçalves
Fonte: Pharmaceutics. Unidade: IQSC
Assuntos: NEOPLASIAS, QUIMIOTERAPIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACHADO, Raiane Aparecida dos Santos et al. A new heteroleptic Zn(II) complex with Schiff bases sensitizes triple-negative breast cancer cells to Doxorubicin and Paclitaxel. Pharmaceutics, v. 16, p. 1610, 2024Tradução . . Disponível em: https://doi.org/10.3390/ pharmaceutics16121610. Acesso em: 05 dez. 2025.
APA
Machado, R. A. dos S., Siqueira, R. P., Silva, F. C. da, Matos, A. C. P. de, Borges, D. S., Rocha, G. G., et al. (2024). A new heteroleptic Zn(II) complex with Schiff bases sensitizes triple-negative breast cancer cells to Doxorubicin and Paclitaxel. Pharmaceutics, 16, 1610. doi:10.3390/ pharmaceutics16121610
NLM
Machado RA dos S, Siqueira RP, Silva FC da, Matos ACP de, Borges DS, Rocha GG, Souza TCP de, Souza RAC, Oliveira CR de, Ferreira AG, Maia PI da S, Deflon VM, Oliveira CG, Araújo TG. A new heteroleptic Zn(II) complex with Schiff bases sensitizes triple-negative breast cancer cells to Doxorubicin and Paclitaxel [Internet]. Pharmaceutics. 2024 ;16 1610.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/ pharmaceutics16121610
Vancouver
Machado RA dos S, Siqueira RP, Silva FC da, Matos ACP de, Borges DS, Rocha GG, Souza TCP de, Souza RAC, Oliveira CR de, Ferreira AG, Maia PI da S, Deflon VM, Oliveira CG, Araújo TG. A new heteroleptic Zn(II) complex with Schiff bases sensitizes triple-negative breast cancer cells to Doxorubicin and Paclitaxel [Internet]. Pharmaceutics. 2024 ;16 1610.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/ pharmaceutics16121610
Artigo de periodico
Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment (2024)
Dartora, Vanessa Franco Carvalho ; Passos, Julia Sapienza ; Panitch, Alyssa ; Costa-Lotufo, Letícia Veras ; Lopes, Luciana Biagini
Fonte: Pharmaceutics. Unidade: ICB
Assuntos: FARMACOLOGIA, NANOPARTÍCULAS, ANTINEOPLÁSICOS, NEOPLASIAS MAMÁRIAS, CITOTOXINAS, FERIMENTOS E LESÕES, QUIMIOTERÁPICOS, CARCINOGÊNESE, MAMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
DARTORA, Vanessa Franco Carvalho et al. Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment. Pharmaceutics, v. 16, n. 2, p. 27 , 2024Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics16020231. Acesso em: 05 dez. 2025.
APA
Dartora, V. F. C., Passos, J. S., Panitch, A., Costa-Lotufo, L. V., & Lopes, L. B. (2024). Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment. Pharmaceutics, 16( 2), 27 . doi:10.3390/pharmaceutics16020231
NLM
Dartora VFC, Passos JS, Panitch A, Costa-Lotufo LV, Lopes LB. Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment [Internet]. Pharmaceutics. 2024 ; 16( 2): 27 .[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics16020231
Vancouver
Dartora VFC, Passos JS, Panitch A, Costa-Lotufo LV, Lopes LB. Thermosensitive polymeric nanoparticles for drug Co-encapsulation and breast cancer treatment [Internet]. Pharmaceutics. 2024 ; 16( 2): 27 .[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics16020231
Artigo de periodico
Drug nanocrystals in oral absorption: factors that influence pharmacokinetics (2024)
Macedo, Luiza de Oliveira ; Masiero, Jéssica Fagionato ; Bou-Chacra, Nadia Araci
Fonte: Pharmaceutics. Unidade: FCF
Assuntos: FARMACOCINÉTICA, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACEDO, Luiza de Oliveira e MASIERO, Jéssica Fagionato e BOU-CHACRA, Nadia Araci. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, v. 16, n. 9, p. 1-21 art. 1141, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16091141. Acesso em: 05 dez. 2025.
APA
Macedo, L. de O., Masiero, J. F., & Bou-Chacra, N. A. (2024). Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, 16( 9), 1-21 art. 1141. doi:10.3390/pharmaceutics16091141
NLM
Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141
Vancouver
Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141
Artigo de periodico
In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors (2024)
Yousef, Malaz ; O’Croinin, Conor; Le, Tyson S; Park, Chulhun ; Zuo, Jieyu; Bou-Chacra, Nadia Araci ; Davies, Neal M ; Löbenberg, Raimar
Fonte: Pharmaceutics. Unidade: FCF
Assuntos: FARMACOCINÉTICA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 05 dez. 2025.
APA
Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768
NLM
Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
Vancouver
Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2025 dez. 05 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
Artigo de periodico
Use of Plant Extracts in Polymeric Scaffolds in the Regeneration of Mandibular Injuries (2024)
Oliveira, Bruna Eduarda Granda de; Maia, Fernanda Latorre Melgaço; Massimino, Lívia Contini ; Garcia, Cláudio Fernandes; Plepis, Ana Maria de Guzzi ; Martins, Virginia da Conceição Amaro ; Reis, Carlos Henrique Bertoni ; Silva, Vinícius Rodrigues ; Bezerra, Andre Alves; Pauris, Carolina Chen; Buchaim, Daniela Vieira; Silva, Yggor Biloria e; Buchaim, Rogério Leone ; Cunha, Marcelo Rodrigues da
Fonte: Pharmaceutics. Unidades: IQSC, FOB, Interunidades em Bioengenharia
Assuntos: COLÁGENO, ELASTINA, POLÍMEROS (MATERIAIS), REPARO ÓSSEO, REGENERAÇÃO ÓSSEA, ROMÃ
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OLIVEIRA, Bruna Eduarda Granda de et al. Use of Plant Extracts in Polymeric Scaffolds in the Regeneration of Mandibular Injuries. Pharmaceutics, v. 16, n. 4, p. 491, 2024Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics16040491. Acesso em: 05 dez. 2025.
APA
Oliveira, B. E. G. de, Maia, F. L. M., Massimino, L. C., Garcia, C. F., Plepis, A. M. de G., Martins, V. da C. A., et al. (2024). Use of Plant Extracts in Polymeric Scaffolds in the Regeneration of Mandibular Injuries. Pharmaceutics, 16( 4), 491. doi:10.3390/pharmaceutics16040491
NLM
Oliveira BEG de, Maia FLM, Massimino LC, Garcia CF, Plepis AM de G, Martins V da CA, Reis CHB, Silva VR, Bezerra AA, Pauris CC, Buchaim DV, Silva YB e, Buchaim RL, Cunha MR da. Use of Plant Extracts in Polymeric Scaffolds in the Regeneration of Mandibular Injuries [Internet]. Pharmaceutics. 2024 ;16( 4): 491.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics16040491
Vancouver
Oliveira BEG de, Maia FLM, Massimino LC, Garcia CF, Plepis AM de G, Martins V da CA, Reis CHB, Silva VR, Bezerra AA, Pauris CC, Buchaim DV, Silva YB e, Buchaim RL, Cunha MR da. Use of Plant Extracts in Polymeric Scaffolds in the Regeneration of Mandibular Injuries [Internet]. Pharmaceutics. 2024 ;16( 4): 491.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics16040491
Artigo de periodico
Protium spruceanum extract enhances mupirocin activity when combined with nanoemulsion-based hydrogel: A multi-target strategy for treating skin and soft tissue infections (2024)
Amparo, Tatiane Roquete ; Sousa, Lucas Resende Dutra ; Xavier, Viviane Flores; Seibert, Janaína Brandão ; Paiva, Débora Luiza; Silva, Débora dos Santos da; Teixeira, Luiz Fernando de Medeiros; Santos, Orlando David Henrique dos ; Vieira, Paula Melo de Abreu ; Souza, Gustavo Henrique Bianco de; Brandão, Geraldo Célio
Fonte: Pharmaceutics. Unidade: ESALQ
Assuntos: AGENTES ANTIMICROBIANOS, ANTIBIÓTICOS, DOENÇAS DA PELE E DO TECIDO CONJUNTIVO, FÁRMACOS DE ORIGEM VEGETAL, PRODUTOS NATURAIS, SINERGISMO DE DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
AMPARO, Tatiane Roquete et al. Protium spruceanum extract enhances mupirocin activity when combined with nanoemulsion-based hydrogel: A multi-target strategy for treating skin and soft tissue infections. Pharmaceutics, v. 16, p. 1-18, 2024Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics16060700. Acesso em: 05 dez. 2025.
APA
Amparo, T. R., Sousa, L. R. D., Xavier, V. F., Seibert, J. B., Paiva, D. L., Silva, D. dos S. da, et al. (2024). Protium spruceanum extract enhances mupirocin activity when combined with nanoemulsion-based hydrogel: A multi-target strategy for treating skin and soft tissue infections. Pharmaceutics, 16, 1-18. doi:10.3390/pharmaceutics16060700
NLM
Amparo TR, Sousa LRD, Xavier VF, Seibert JB, Paiva DL, Silva D dos S da, Teixeira LF de M, Santos ODH dos, Vieira PM de A, Souza GHB de, Brandão GC. Protium spruceanum extract enhances mupirocin activity when combined with nanoemulsion-based hydrogel: A multi-target strategy for treating skin and soft tissue infections [Internet]. Pharmaceutics. 2024 ; 16 1-18.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics16060700
Vancouver
Amparo TR, Sousa LRD, Xavier VF, Seibert JB, Paiva DL, Silva D dos S da, Teixeira LF de M, Santos ODH dos, Vieira PM de A, Souza GHB de, Brandão GC. Protium spruceanum extract enhances mupirocin activity when combined with nanoemulsion-based hydrogel: A multi-target strategy for treating skin and soft tissue infections [Internet]. Pharmaceutics. 2024 ; 16 1-18.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics16060700
Artigo de periodico
Geraniol potentiates the effect of fluconazole against planktonic and sessile cells of Azole-Resistant Candida tropicalis: in vitro and in vivo analyses (2024)
Silva-Rodrigues, Gislaine ; Castro, Isabela Madeira de ; Borges, Paulo Henrique Guilherme ; Suzukawa, Helena Tiemi ; Souza, Joyce Marinho de ; Bartolomeu-Gonçalves, Guilherme ; Pelisson, Marsileni ; Medeiros, Cássio Ilan Soares ; Bispo, Marcelle de Lima Ferreira ; Almeida, Ricardo Sergio Couto de ; Tavares, Eliandro Reis ; Yamauchi, Lucy Megumi ; Yamada-Ogatta, Sueli Fumie ; Ishida, Kelly
Fonte: Pharmaceutics. Unidade: ICB
Assuntos: MICROBIOLOGIA, ANTIFÚNGICOS, LEVEDURAS, BIOFILMES, LEPIDOPTERA, CANDIDA, TOXINAS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVA-RODRIGUES, Gislaine et al. Geraniol potentiates the effect of fluconazole against planktonic and sessile cells of Azole-Resistant Candida tropicalis: in vitro and in vivo analyses. Pharmaceutics, v. 16, n. 8, p. 25 , 2024Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics16081053. Acesso em: 05 dez. 2025.
APA
Silva-Rodrigues, G., Castro, I. M. de, Borges, P. H. G., Suzukawa, H. T., Souza, J. M. de, Bartolomeu-Gonçalves, G., et al. (2024). Geraniol potentiates the effect of fluconazole against planktonic and sessile cells of Azole-Resistant Candida tropicalis: in vitro and in vivo analyses. Pharmaceutics, 16( 8), 25 . doi:10.3390/pharmaceutics16081053
NLM
Silva-Rodrigues G, Castro IM de, Borges PHG, Suzukawa HT, Souza JM de, Bartolomeu-Gonçalves G, Pelisson M, Medeiros CIS, Bispo M de LF, Almeida RSC de, Tavares ER, Yamauchi LM, Yamada-Ogatta SF, Ishida K. Geraniol potentiates the effect of fluconazole against planktonic and sessile cells of Azole-Resistant Candida tropicalis: in vitro and in vivo analyses [Internet]. Pharmaceutics. 2024 ; 16( 8): 25 .[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics16081053
Vancouver
Silva-Rodrigues G, Castro IM de, Borges PHG, Suzukawa HT, Souza JM de, Bartolomeu-Gonçalves G, Pelisson M, Medeiros CIS, Bispo M de LF, Almeida RSC de, Tavares ER, Yamauchi LM, Yamada-Ogatta SF, Ishida K. Geraniol potentiates the effect of fluconazole against planktonic and sessile cells of Azole-Resistant Candida tropicalis: in vitro and in vivo analyses [Internet]. Pharmaceutics. 2024 ; 16( 8): 25 .[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics16081053
Artigo de periodico
Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents (2024)
Borges, Alice Prudente; Obata, Malu Mateus Santos; Libardi, Silvia H. ; Trevisan, Rafael O.; Deflon, Victor Marcelo ; Abram, Ulrich ; Ferreira, Francis B.; Costa, Luiz Antônio S.; Patrocínio, Antonio Otavio de Toledo ; Silva, Marcos V. da; Borges, Julio Cesar ; Maia, Pedro Ivo da Silva
Fonte: Pharmaceutics. Unidade: IQSC
Assuntos: SULFONAMIDAS, OURO, PRATA, LEISHMANIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Alice Prudente et al. Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents. Pharmaceutics, v. 16, p. 452, 2024Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics16040452. Acesso em: 05 dez. 2025.
APA
Borges, A. P., Obata, M. M. S., Libardi, S. H., Trevisan, R. O., Deflon, V. M., Abram, U., et al. (2024). Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents. Pharmaceutics, 16, 452. doi:10.3390/pharmaceutics16040452
NLM
Borges AP, Obata MMS, Libardi SH, Trevisan RO, Deflon VM, Abram U, Ferreira FB, Costa LAS, Patrocínio AO de T, Silva MV da, Borges JC, Maia PI da S. Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents [Internet]. Pharmaceutics. 2024 ;16 452.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics16040452
Vancouver
Borges AP, Obata MMS, Libardi SH, Trevisan RO, Deflon VM, Abram U, Ferreira FB, Costa LAS, Patrocínio AO de T, Silva MV da, Borges JC, Maia PI da S. Gold(I) and Silver(I) Complexes Containing Hybrid Sulfonamide/Thiourea Ligands as Potential Leishmanicidal Agents [Internet]. Pharmaceutics. 2024 ;16 452.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics16040452
Artigo de periodico
Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet (2023)
Leon, Rosmery Merma ; Issa, Michele Georges ; Duque, Marcelo Dutra ; Daniel, Josiane Souza Pereira ; Ferraz, Humberto Gomes
Fonte: Pharmaceutics. Unidade: FCF
Assunto: PLANEJAMENTO DE FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEON, Rosmery Merma et al. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet. Pharmaceutics, v. 15, p. 1-20 art. 1735, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15061735. Acesso em: 05 dez. 2025.
APA
Leon, R. M., Issa, M. G., Duque, M. D., Daniel, J. S. P., & Ferraz, H. G. (2023). Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet. Pharmaceutics, 15, 1-20 art. 1735. doi:10.3390/pharmaceutics15061735
NLM
Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet [Internet]. Pharmaceutics. 2023 ; 15 1-20 art. 1735.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics15061735
Vancouver
Leon RM, Issa MG, Duque MD, Daniel JSP, Ferraz HG. Development of a discriminative dissolution method, using in-silico tool for Hydrochlorothiazide and Valsartan tablet [Internet]. Pharmaceutics. 2023 ; 15 1-20 art. 1735.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics15061735
Artigo de periodico
Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein (2023)
Bitencourt, Natália Vitória ; Righetto, Gabriela Marinho; Camargo, Ilana Lopes Baratella da Cunha ; Godoy, Mariana Ortiz de ; Guido, Rafael Victorio Carvalho ; Oliva, Glaucius ; Santos Filho, Norival Alves ; Cilli, Eduardo Maffud
Fonte: Pharmaceutics. Unidade: IFSC
Assuntos: COVID-19, CORONAVIRUS, PEPTÍDEOS, RESISTÊNCIA MICROBIANA ÀS DROGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BITENCOURT, Natália Vitória et al. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, v. 15, n. 2, p. 436-1-436-17 + supplementary materials: 1-8, 2023Tradução . . Disponível em: https://doi.org/10.3390/pharmaceutics15020436. Acesso em: 05 dez. 2025.
APA
Bitencourt, N. V., Righetto, G. M., Camargo, I. L. B. da C., Godoy, M. O. de, Guido, R. V. C., Oliva, G., et al. (2023). Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein. Pharmaceutics, 15( 2), 436-1-436-17 + supplementary materials: 1-8. doi:10.3390/pharmaceutics15020436
NLM
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics15020436
Vancouver
Bitencourt NV, Righetto GM, Camargo ILB da C, Godoy MO de, Guido RVC, Oliva G, Santos Filho NA, Cilli EM. Effects of dimerization, dendrimerization, and chirality in p-BthTX-I peptide analogs on the antibacterial activity and enzymatic inhibition of the SARS-CoV-2 PLpro protein [Internet]. Pharmaceutics. 2023 ; 15( 2): 436-1-436-17 + supplementary materials: 1-8.[citado 2025 dez. 05 ] Available from: https://doi.org/10.3390/pharmaceutics15020436

Unidades USP

ReP

Filtros

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Grupo de pesquisa

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos